The Global Lysosomal Disease Treatments Market has been experiencing significant growth as advancements in medical research and biotechnology enable improved care for rare genetic disorders. Global lysosomal disease treatments market size was valued at USD 11.89 billion in 2024 and is projected to reach USD 26.42 billion by 2032, with a CAGR of...